
Carl Zeiss Meditec Reports Revenue Growth for Fiscal Year 2024-2025
Published on December 15, 2025
JENA, Germany—Carl Zeiss Meditec has announced its financial results for fiscal year 2024-2025, reporting revenue of €2,228 million, an increase of 7.8 percent compared with revenue of €2,066 million in the prior year. EBITA rose to €257.7 million versus the prior year’s €248.9 million. Order intake reached €2,288 million, an increase of 18.2 percent, with growth reported across all regions, the group advised. Order backlog amounted to €380 million, remaining at an elevated level of 16.1 percent compared with the previous year.
